RPH PHARMA LTDActive

Company number 11330646Private limited companyIncorporated 2018

Key figures

£1,336,053+116.9%
Net assets 2024
+4.8%
Average annual growth 2020–2024
0500 k1 m1.5 m2020202220232024

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m2020202220232024
Filed accounts2020–2024
2020202220232024
Turnover1,002,1031,930,3462,872,98813,533,970
Profit for the year186,500471,358456,878720,048
Cash at bank and in hand1,011,784970,669480,795—
Total assets1,337,5751,112,2101,401,10111,141,001
Total liabilities177,928953,083785,0969,804,948
Net assets / total equity1,159,647159,127616,0051,336,053
Average number of employees0005
Average pay (per year)———108,162

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

The principal activity of the company during the year was marketing the sale of pharmaceuticals.

As described in the company's latest filed accounts.

Summary: RPH PHARMA LTD

Company

RPH PHARMA LTD is a private limited company registered with Companies House under company number 11330646. It was incorporated on 26 Apr 2018. Its status is active. The registered office is in Cheadle royal business park (SK8). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Turnover was £13,533,970. Profit for the year was £720,048. Net assets were £1,336,053, up 116.9% on the previous year. Total assets were £11,141,001 and total liabilities £9,804,948. The company had an average of 5 employees. Figures are available for 4 financial years (2020–2024).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 9 May 2027.